Navigation Links
Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
Date:12/8/2007

HAYWARD, Calif., Dec. 8 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) presented updated data from a dose-escalating Phase 1b clinical trial of Hsp90 inhibitor tanespimycin (KOS-953) in combination with bortezomib (Velcade(R)), showing durable antitumor activity and tolerability in patients with multiple myeloma who had previously progressed following treatment with multiple conventional therapies. The data presentation includes summary aggregate results from patients treated with all doses of Kosan's prior Cremophor-containing formulation and with Kosan's new injectable suspension formulation. Responses were seen across dose levels in the bortezomib-naive, pre-treated and refractory patients. Both formulations demonstrated activity, and the combination was manageable relative to safety, with no Grade 3 neurotoxicity to date. This finding supports the potential neuroprotective effect of tanespimycin. The data were presented on Saturday, December 8, 2007, by Paul Richardson, M.D., Department of Hematology, Dana Farber Cancer Center, Boston, MA, in a poster titled "Tanespimycin (T) + Bortezomib (BZ) in Multiple Myeloma (MM): Confirmation of the Recommended Dose Using a Novel Formulation," at the 2007 Annual Meeting of the American Society of Hematology (ASH).

"Tanespimycin continues to be of interest as a potential treatment for patients with multiple myeloma who have failed prior regimens due to its tolerability and potential for additive or synergistic activity with bortezomib," said Kenneth C. Anderson, M.D., Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, senior author on the poster. "The new injectable suspension formulation appears to be
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
8. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
9. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , CHICAGO, Nov. 30 Minimally...re costly open surgery, particularly in oncology, ...a global market for image-guided navigation expect...mbracing the advantages offered by minimally-invas... times, greater patient comfort and faster patient...
(Date:11/30/2009)... , TEL AVIV, Israel, November 30 /PRNewswi... the FOMRI-III(TM) dual channel microphone, the mo...n functional magnetic resonance imaging,(fMRI) env...epresents a major step forward for fiber,optic mic...quality ever, with,low-latency adaptive noise canc...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Stemline T...rmaceutical company and leading developer of oncol... announced that The University of Texas M.D. Ander...entered into a research collaboration. As part of ...going Phase I/II clinical trial of SL-401 in patie...
Breaking Medicine Technology:Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center 2iSirona Announces Go live at University Hospitals in Cleveland 14887 1iSirona Announces Go live at University Hospitals in Cleveland 14887 2iSirona Announces Go live at University Hospitals in Cleveland 14887 3Call an Economic 26quot 3BAudible 26quot 3B With a Midbrook Rebuilt Parts Washer 61593 1Call an Economic 26quot 3BAudible 26quot 3B With a Midbrook Rebuilt Parts Washer 61593 2Call an Economic 26quot 3BAudible 26quot 3B With a Midbrook Rebuilt Parts Washer 61593 3Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 1Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 2Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 3
(Date:11/30/2009)... , LOS ANGELES, Nov. 30 ...a woman, and brings with it a host of uncomfortabl... Hot flashes, poor sleep, mood swings, weight gai... life-altering symptoms of menopause and perimenop... can show up a full ten years before actual menopa...
(Date:11/30/2009)... , Study Uses Tent To S...NEW YORK, Nov. 30 Dista...ygen levels are known to improve their performance...n heart failure patients, who suffer from fatigue,...a tent-like, high-altitude simulator? ,, That i...
(Date:11/30/2009)... , GAINESVILLE, Fla., Nov. 30 ...CAD marks the availability of the first FDA-cleare...tection and analysis by a radiologist of suspiciou...lly unveiled at the Radiological Society of North ...loped in partnership with leading experts in breas...
(Date:11/30/2009)... lab studies report safe transplant results in ani...ws) -- Two new studies in animals suggest that ste...cord blood could help treat some lung and heart di...tem cells can differentiate into a long list of di...Soon Park of the Samsung Medical Center in Seoul, ...
(Date:11/30/2009)... , WASHINGTON, Nov. 30 - Salon... Cause" on Monday, December 7(th) to raise funds a...ldhood terminal diseases. All proceeds from each h...ildren,s Research Hospital. ,, Salon Leau has ...s. The salon is owned by LoAnn Lai, widely recogni...
Breaking Medicine News(10 mins):Health News:Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2
...ulous properties, Herceptin, the breast cancer won...British medical journal questioned its effectivene...t to make reliable judgments. It is profoundly mis...rticle that was released online on Wednesday. This...
...lity, second only to infanticide in Asian countrie... student of economics at Harvard University//, fou...he uncommonly high male to female ratios in many A... of the population is infected. Oster presen...
...national company to bring a cost effective vaccine...ealth Minister Anbumani Ramadoss //on the occasion...gh rate of cervical cancer has been instrumental b... which has produced the vaccine. Trial of the vacc...
...ng on personal values can keep neuroendocrine and ... Stress is implicated in the development //and pr...health disorders. Theory and research on the sel...gical Science, reflects on this issue. The researc...
...by Sri the Art of Living Foundation spiritual head...t discrimination based on gender and concern was s... All the religious leaders were present in the m...ion of girl child in many parts of our country. ...
...r avian flu scare has acquired this nasty habit of...turned out to be man's greatest enemies in the 21s...y are the origins of this disease// and what exact...well as domesticated ones including chickens, duck...
Other Medicine News:Health News:Herceptin Not A ‘Wonder’ Drug, Says The Lanc 2Health News:Cervical Cancer Vaccine To Be Developed In India 2Health News:A bird's eye view of the Bird Flu scare 2
Scorpio TS Single Axis Revision Knee System
...turers focus attention on implant design, one crit...he Profix Total Knee System seeks to establish a b...he tools to implant them. Designed by Leo A. White...tal knee instrumentation, Profix instruments are ...
Ascent Primary Knee System - Ascent posterior stabilized/constrainable closed box femoral components.
Ascent Primary Knee System - Ascent primary interlock femoral components.
Medicine Products: